DrugPatentWatch Database Preview

Chartwell Molecules Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty approved drugs.

Summary for Chartwell Molecules

US Patents:	0
Tradenames:	15
Ingredients:	15
NDAs:	20

Drugs and US Patents for Chartwell Molecules

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecules	DISULFIRAM	disulfiram	TABLET;ORAL	091563-002	Dec 31, 2012	AB	RX	No	No
Chartwell Molecules	ONDANSETRON	ondansetron	TABLET, ORALLY DISINTEGRATING;ORAL	077406-001	Dec 26, 2006		DISCN	No	No
Chartwell Molecules	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	077303-004	Jun 25, 2007		DISCN	No	No
Chartwell Molecules	SELEGILINE HYDROCHLORIDE	selegiline hydrochloride	TABLET;ORAL	074641-001	Aug 2, 1996		DISCN	No	No
Chartwell Molecules	NABUMETONE	nabumetone	TABLET;ORAL	076009-001	Jan 24, 2003	AB	RX	No	No
Chartwell Molecules	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	077303-002	Jun 25, 2007		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chartwell
• Chartwell Life Sci
• Chartwell Molecular
• Chartwell Molecules
• Chartwell Pharma
• Chartwell Rx